Harvest Portfolios Group Inc. Has $1.03 Million Holdings in Healthpeak Properties, Inc. $DOC

Harvest Portfolios Group Inc. lessened its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 31.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 64,328 shares of the real estate investment trust’s stock after selling 29,496 shares during the quarter. Harvest Portfolios Group Inc.’s holdings in Healthpeak Properties were worth $1,034,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of DOC. JPMorgan Chase & Co. grew its holdings in shares of Healthpeak Properties by 41.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock worth $540,730,000 after purchasing an additional 8,212,504 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Healthpeak Properties by 694.6% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock worth $153,520,000 after purchasing an additional 7,007,777 shares in the last quarter. Equity Investment Corp boosted its stake in Healthpeak Properties by 209.6% in the 3rd quarter. Equity Investment Corp now owns 5,330,948 shares of the real estate investment trust’s stock valued at $102,088,000 after buying an additional 3,608,849 shares in the last quarter. Bank of America Corp DE boosted its stake in Healthpeak Properties by 28.5% in the 3rd quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust’s stock valued at $190,292,000 after buying an additional 2,206,222 shares in the last quarter. Finally, Russell Investments Group Ltd. boosted its stake in Healthpeak Properties by 176.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 3,063,569 shares of the real estate investment trust’s stock valued at $58,663,000 after buying an additional 1,955,273 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

Healthpeak Properties stock opened at $19.70 on Thursday. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The firm has a market cap of $13.58 billion, a P/E ratio of 61.55, a P/E/G ratio of 2.45 and a beta of 1.00. The business’s fifty day moving average is $17.39 and its two-hundred day moving average is $17.23. Healthpeak Properties, Inc. has a 52 week low of $15.70 and a 52 week high of $19.91.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The company had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The business’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities research analysts forecast that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be paid a $0.1017 dividend. The ex-dividend date of this dividend is Monday, June 15th. This represents a c) dividend on an annualized basis and a yield of 6.2%. Healthpeak Properties’s payout ratio is currently 381.25%.

Insider Buying and Selling

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.23% of the company’s stock.

Wall Street Analysts Forecast Growth

DOC has been the topic of several recent analyst reports. Royal Bank Of Canada boosted their price target on Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research note on Thursday, May 14th. Argus lowered Healthpeak Properties from a “buy” rating to a “hold” rating in a research note on Thursday, February 5th. Robert W. Baird boosted their price target on Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Morgan Stanley decreased their price target on Healthpeak Properties from $21.00 to $18.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 28th. Finally, Weiss Ratings raised Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Five research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $18.92.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.